SCHEMBL17458

SCHEMBL17458

CNC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL530404 1.00 KDM1A (0.38) —
SCHEMBL665282 1.00 KDM1A (0.38) —
SCHEMBL11525280 1.00 KDM1A (0.38) —
SCHEMBL27381972 1.00 KDM1A (0.38) —
Hydrochloric Acid SCHEMBL932936 0.96 — —
Hydrochloric Acid SCHEMBL8648518 0.96 KDM1A (0.37) —
Hydrochloric Acid SCHEMBL8308713 0.96 — —
Hydrochloric Acid SCHEMBL8648521 0.96 KDM1A (0.37) —
Methane SCHEMBL27788609 0.96 — —
Hydrochloric Acid SCHEMBL4166670 0.92 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5742 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3963648-B1 METHOD OF PREPARING CATHODE FOR SECONDARY BATTERY GRST INT LTD (CN) 2025-02-26 — — EP claimed
WO-2024094170-A1 INHIBITOR OF UBIQUITIN-SPECIFIC PROTEASE 1 AND USE THEREOF 深圳晶泰科技有限公司 2024-05-10 — — WO claimed
US-20240124474-A1 HER2 MUTATION INHIBITORS ARRAY BIOPHARMA INC. (US) 2024-04-18 — — US claimed
CN-115894486-B Hydrogenated pyridoquinazoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2024-02-09 — — CN claimed
WO-2024003259-A1 TEAD INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2024-01-04 — — WO claimed
US-11855272-B2 Cathode slurry for secondary battery GRST INTERNATIONAL LIMITED (CN) 2023-12-26 — — US claimed
EP-4293016-A1 QUINAZOLINE-BASED COMPOUND, COMPOSITION, AND APPLICATION OF QUINAZOLINE-BASED COMPOUND Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2023-12-20 — — EP claimed
CN-113527215-B Quinazoline compound, preparation method and application thereof 北京赛特明强医药科技有限公司 2023-12-05 — — CN claimed
US-11806346-B2 HTT modulators for treating Huntington's disease CHDI FOUNDATION, INC. (US) 2023-11-07 — — US claimed
CN-116997548-A HTT modulators for the treatment of huntington's disease CHDI基金会股份有限公司 2023-11-03 — — CN claimed
EP-0061746-B1 PHOSPHORAMIDITE COMPOUNDS AND THEIR USE IN PRODUCING OLIGONUCLEOTIDES UNIVERSITY PATENTS, INC. (US) 1985-03-20 — — EP claimed
WO-1984004749-A1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES BECKMAN INSTRUMENTS INC (US) 1984-12-06 — — WO claimed
EP-0105166-A1 Substituted tert. butanol derivatives, method for their preparation and antimycotic agents containing them BAYER AG (DE) 1984-04-11 — — EP claimed
US-4434287-A Cephalosporin derivatives CIBA-GEIGY CORPORATION (US) 1984-02-28 — — US claimed
US-4415732-A STORAGE-STABLE NUCLEOSIDES; POLYNUCLEOTIDE SYNTHESIS UNIVERSITY PATENTS, INC. (US) 1983-11-15 — — US claimed
US-4319027-A Process for the manufacture of ceohem enol derivatives CIBA-GEIGY CORPORATION (US) 1982-03-09 — — US claimed
US-4293462-A Process for the manufacture of enol derivatives, and intermediates CIBA-GEIGY CORPORATION (US) 1981-10-06 — — US claimed
US-4110533-A PROCESS FOR THE MANUFACTURE OF ENOL DERIVATIVES CIBA-GEIGY CORPORATION (US) 1978-08-29 — — US claimed
US-4058662-A Process for the substitution of chlorine atoms of cyanuric chloride DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1977-11-15 — — US claimed
US-4054739-A Process for the substitution of chlorine atoms of cyanuric chloride DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1977-10-18 — — US claimed
Send feedback